You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. LIXTE Biotechnology Holdings Provides Corporate Update
- 2. FDA-approved MI cancer seek test enhances tumour profiling for precision oncology
- 3. Efficacy prediction of neoadjuvant cadonilimab plus FLOT therapy for advanced gastric cancer: a study based on body composition changes
- 4. Association between advanced lung cancer inflammation index and distant metastasis in breast cancer: a retrospective cohort study
- 5. First two subjects enrolled in Biodexa's Phase III trial for FAP treatment
- 6. 24/7 Market News: LIXTE Biotechnology Spotlight- Revisiting the "Too Much of a Good Thing" Strategy for LB-100
- 7. Primary vulval sebaceous carcinoma: rare case report and literature review
- 8. Combined neoadjuvant chemotherapy and immunotherapy in a hepatitis B virus-positive patient with locally advanced rectal adenocarcinoma: a case report and literature review
- 9. Minimally invasive surgical treatment for sigmoid colon cancer in a patient with situs inversus totalis: a case report
- 10. AI model developed by Dresden research team simultaneously detects multiple genetic colorectal cancer markers in tissue samples
Last updated at 1:39 GMT
Hot News Makers
Health/Pharma Companies
-
19150.73
-
11682.77
-
10880.14
-
8542.53
-
8270.07
-
7074.05
-
6906.51
-
6903.93
-
6562.64
-
6333.92
Drugs, Treatments, Trials
-
15432.54
-
15241.24
-
14630.29
-
9429.15
-
7133.01
-
6682.44
-
6646.77
-
5741.31
-
5731.06
-
5188.30
Last updated at 1:10 GMT
